US 11236338
Antisense-induced exon2 inclusion in acid alpha-glucosidase
granted A61PA61P3/08A61P3/10
Quick answer
US patent 11236338 (Antisense-induced exon2 inclusion in acid alpha-glucosidase) held by Sarepta Therapeutics, Inc. expires Mon Jan 27 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Sarepta Therapeutics, Inc.
- Grant date
- Tue Feb 01 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 27 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 8
- CPC classes
- A61P, A61P3/08, A61P3/10, A61P43/00